11 pending office actions • 2 clients
| Client (Assignee) | Pending OAs |
|---|---|
| Dyne Therapeutics, Inc. | 10 |
| Dyne Therapeutics, Lnc. | 1 |
| App # | Title | Client | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|---|
| 19382888 | Untitled | Dyne Therapeutics, Inc. | CANELLA, KAREN A | 1643 | Non-Final OA | |
| 18270324 | MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING MYOTONIC DYSTROPHY | Dyne Therapeutics, Inc. | GIBBS, TERRA C | 1635 | Non-Final OA | Jun 29, 2023 |
| 18024486 | METHODS OF PREPARING PROTEIN-OLIGONUCLEOTIDE COMPLEXES | Dyne Therapeutics, Inc. | HUYNH, PHUONG N | 1641 | Non-Final OA | Mar 02, 2023 |
| 18017167 | ANTI-TRANSFERRIN RECEPTOR (TFR) ANTIBODY AND USES THEREOF | Dyne Therapeutics, Lnc. | LANDSMAN, ROBERT S | 1647 | Non-Final OA | Jan 20, 2023 |
| 18017173 | MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY | Dyne Therapeutics, Inc. | YAO, LEI | 1642 | Non-Final OA | Jan 20, 2023 |
| 18017179 | MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING DYSTROPHINOPATHIES | Dyne Therapeutics, Inc. | ROSSI, JULIA ANNE LORRAIN | 1615 | Final Rejection | Jan 20, 2023 |
| 18017182 | MUSCLE-TARGETING COMPLEXES AND USES THEREOF IN TREATING MUSCLE ATROPHY | Dyne Therapeutics, Inc. | ROSSI, JULIA ANNE LORRAIN | 1615 | Non-Final OA | Jan 20, 2023 |
| 17794768 | MUSCLE-TARGETING COMPLEXES AND USES THEREOF IN TREATING MUSCLE ATROPHY | Dyne Therapeutics, Inc. | EMCH, GREGORY S | 1678 | Final Rejection | Jul 22, 2022 |
| 17791667 | MUSCLE-TARGETING COMPLEXES AND USES THEREOF | Dyne Therapeutics, Inc. | NOAKES, SUZANNE MARIE | 1656 | Final Rejection | Jul 08, 2022 |
| 17791697 | MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY | Dyne Therapeutics, Inc. | YAO, LEI | 1642 | Final Rejection | Jul 08, 2022 |
| 17791681 | MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING MYOTONIC DYSTROPHY | Dyne Therapeutics, Inc. | HADDAD, MAHER M | 1641 | Final Rejection | Jul 08, 2022 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial